Journal
CELLULAR SIGNALLING
Volume 18, Issue 9, Pages 1376-1385Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2005.10.016
Keywords
IL-1; Cot/tpl-2; ERK1/ERK2; IL-8; MIP-1 beta; TRAF6 Src tyrosine kinases
Categories
Ask authors/readers for more resources
Cot is one of the MAP kinase kinase kinases that regulates the ERK1/ERK2 pathway under physiological conditions. Cot is activated by LPS, by inducing its dissociation from the inactive p 105 NF kappa B-Cot complex in macrophages. Here, we show that IL-1 promotes a 10-fold increase in endogenous Cot activity and that Cot is the only MAP kinase kinase kinase that activates ERK1/ERK2 in response to this cytokine. Moreover, in cells where the expression of Cot is blocked, IL-I fails to induce an increase in IL-8 and MTP-1 beta mRNA levels. The activation of Cot-MKK1-ERK1/ERK2 signalling pathway by IL-I is dependent on the activity of the transducer protein TRAF6. Most important, IL-1-induced ERK1/ERK2 activation is inhibited by PP1, a known inhibitor of Src tyrosine kinases, but this tyrosine kinase activity is not required for IL-1 to activate other MAP kinases such as p38 and JNK. This Src kinases inhibitor does not block the dissociation and subsequently degradation of Cot in response to IL-I, indicating that other events besides Cot dissociation are required to activate Cot. All these data highlight the specific requirements for activation of the Cot-MKK1-ERK1/ERK2 pathway and provide evidence that Cot controls the functions of IL-I that are mediated by ERK1/ERK2. (c) 2005 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available